Faster clarification of acute heart attacks at the Emergency Department (Legevakten) in Oslo (OUT-ACS-studien)
Improving the safety of oral anticoagulants
The BETAMI trial (national trial on the use of beta blockers in myocardial infarction)
Detecting changes in cardiac extracellular matrix – identification of novel biomarkers
Quality of care and outcome in acute myocardial infarction - A population-based study
Heart failure in Norway – a registry-based approach
The role of genetic factors in acute myocardial infarction
Use of Music therapy in Cardiac Implantable Electronic Device (CIED) lead extractions
Hyperemesis gravidarum and cardiovascular disease
Involved in SMINC (MINOCA Myocardial Infarction with Non-Obstructrive Coronary Arteries), EXHAUSTION (Exposure to heat and air pollution in Europe – cardiopulmonary impacts and benefits of mitigation and adaptation), PSARA (Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients, and the PROG-IMT
Knudsen Pope M, Hall TS, Virdone S, Atar D, John Camm A, Pieper KS, Jansky P, Haas S, Goto S, Panchenko E, Baron-Esquivias G, Angchaisuksiri P, Kakkar AK, GARFIELD-AF Investigators(2023) Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry Int J Cardiol Heart Vasc, 49, 101302 DOI 10.1016/j.ijcha.2023.101302, PubMed 38020059
Kristensen AMD, Munkhaugen J, Halvorsen S, Olsen MH, Bakken A, Sehested TSG, Ruddox V, Lange T, Fagerland MW, Torp-Pedersen C, Prescott E, Atar D(2023) The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics Eur Heart J Cardiovasc Pharmacother(in press) DOI 10.1093/ehjcvp/pvad093, PubMed 38017624
Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF, Atar D, Birnie DH, Boriani G, Camm AJ, Conen D, Erath JW, Gold MR, Hohnloser SH, Ip J, Kautzner J, Kutyifa V, Linde C, Mabo P, Mairesse G, Benezet Mazuecos J, Cosedis Nielsen J, Philippon F, Proietti M, Sticherling Cet al.(2023) Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation N Engl J Med(in press) DOI 10.1056/NEJMoa2310234, PubMed 37952132